




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Interventions and ACS</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=9445effd-ba3f-4faa-8061-b82d69552947</link>
        <description>Clinical Topic Feed: Interventions and ACS</description>
        <language>en</language>

        

                <item>
                    <title>Online Exclusive | SCAI 2026 Roundup: Major Coronary, Structural and Vascular Trials From Montr&#195;&#169;al</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/01/Online-Exclusive-SCAI-2026-Roundup</link>                    <description>The 2026 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions and CAIC-ACCI Summit, held in Montr&#195;&#169;al, Canada, highlighted the continuing evolution of interventional cardiology through the presentation of several important late-breaking clinical trials.</description>
                    <pubdate>1782908100000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Consistent Renal Benefit With Semaglutide in T2D/CKD; Late Pericardial Effusion Post LAAO</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1782907800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HOST-EXAM: Clopidogrel vs. Aspirin Monotherapy at 10 Years Post PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/04/07/19/53/host-exam-acc-2026</link>                    <description>Clopidogrel monotherapy after PCI was associated with a significantly lower composite risk of all-cause death, nonfatal MI, stroke, readmission for acute coronary syndrome (ACS) and major bleeding compared with aspirin monotherapy, according to 10-year follow-up results of the HOST-EXAM trial presented as featured clinical research at ACC.26 and published simultaneously in The Lancet.</description>
                    <pubdate>1775593440000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FAST III: Novel Minimally Invasive vFFR Noninferior to FFR For Revascularization</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026</link>                    <description>Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: New ACC/AHA Dyslipidemia Guidelines Released</title>
<link>/Latest-in-Cardiology/Articles/2026/03/18/00/50/eagles-eye-view-18mar2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life.</description>
                    <pubdate>1773842400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>RENOVATE-COMPLEX-PCI: Benefit With Intravascular Imaging Guidance Maintained at 5 Years</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/03/10/16/54/RENOVATE-COMPLEX-PCI-Benefit-With-Intravascular</link>                    <description>In the multicenter open-label superiority trial, Joo Myung Lee, MD, MPH, PhD, FACC, et al., randomized 1,639 patients (mean age 66; 20% women) with complex coronary artery lesions across 20 hospitals in South Korea 2:1 to either intravascular imaging-guided PCI (n=1,092) or angiography-guided PCI (n=547). Of the overall cohort, 49% presented with stable ischemic heart disease and 51% with an acute coronary syndrome (ACS). Thirty-one percent had three or more characteristics of complex coronary artery lesions in the target lesion. The most common was long coronary lesion, followed by multivessel PCI, true bifurcation lesion and chronic total occlusion.</description>
                    <pubdate>1773162180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Can Moderate Wine Intake Reduce CV Risk?</title>
<link>/Latest-in-Cardiology/Articles/2026/03/04/14/11/eagles-eye-view-04mar2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at increased one-year mortality in younger patients undergoing transcatheter aortic valve replacement (TAVR).</description>
                    <pubdate>1772636400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Demystifying Antiplatelet Therapy Duration Following Percutaneous Coronary Intervention</title>
<link>/Latest-in-Cardiology/Articles/2025/12/08/18/14/Demystifying-Antiplatelet-Therapy</link>                    <description>The optimal management of dual antiplatelet therapy (DAPT) in patients presenting with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) remains a dynamic and evolving area.</description>
                    <pubdate>1765224600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Alteplase in Microvascular Obstruction; DCB vs. DES in de Novo CAD</title>
<link>/Latest-in-Cardiology/Articles/2025/12/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1764594300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | TAVR vs. Surgery at 7 Years; DOACs vs. DAPT Post LAAC</title>
<link>/Latest-in-Cardiology/Articles/2025/12/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1764594240000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>